Figure 2.
Kaplan-Meier survival evaluating treatment dropout and relapse.
NI+OP indicates 1000-mg naltrexone implantandoral placebo (n=102);
PI+NO, placebo implant and 50-mg oral naltrexone hydrochloride (n=102);
PI+OP, placebo implant and oral placebo (n=102).